দেশ: জর্ডন
ভাষা: ইংরেজি
সূত্র: JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)
Indacaterol 300 mcg
شركة مستودع الأدوية الأردني - The Jordan Drugstore Co
R03AC18
Indacaterol 300 mcg
300 mcg
30 Cap
Novartis Pharma Stein AG (سويسرا)
37.39 :سعر الجمهور + الضريبة
Onbrez ® Breezhaler ® prescribing information : approved by Swissmedic 04.03.2014 (2013-PSB/GLC-0645-s) Page 1 of 17 Novartis Pharma Schweiz AG Confidential Application no.: 103351 Case manager/Case assistant initials: uf/sr ONBREZ ® BREEZHALER ® Hard capsules containing inhalation powder COMPOSITION _Active substance: _Indacaterol, as indacaterol maleate._ _ _Excipients:_ Lactose monohydrate, capsule excipients, gelatin (capsule shell)._ _ PHARMACEUTICAL FORM AND QUANTITY OF ACTIVE SUBSTANCE PER UNIT Pharmaceutical form _Clear, colourless, hard capsules containing 150 µg of inhalation powder_ with "IDL 150" and company logo printed in black. _Clear, colourless, hard capsules containing 300 µg of inhalation powder_ _ _ with "IDL 300" and company logo printed in blue. _Quantity of active substance_ _Hard capsules containing 150 µg indacaterol, corresponding to 194 µg indacaterol maleate _ The delivered dose (i.e. the dose discharged through the mouthpiece of the Onbrez Breezhaler inhaler) is 120 µg indacaterol maleate. _Hard capsules containing 300 µg indacaterol, corresponding to 389 µg indacaterol maleate _ The delivered dose (i.e. the dose discharged through the mouthpiece of the Onbrez Breezhaler inhaler) is 240 µg indacaterol maleate. INDICATIONS/POTENTIAL USES Onbrez Breezhaler is indicated for maintenance bronchodilator treatment of airflow obstruction in adult patients with chronic obstructive pulmonary disease (COPD). Onbrez ® Breezhaler ® prescribing information : approved by Swissmedic 04.03.2014 (2013-PSB/GLC-0645-s) Page 2 of 17 Novartis Pharma Schweiz AG Confidential Application no.: 103351 Case manager/Case assistant initials: uf/sr DOSAGE/ADMINISTRATION _Dosage _ _Adults _ The recommended dose of Onbrez Breezhaler is the inhalation of the content of one 150 µg capsule once a day, using the Onbrez Breezhaler inhaler. The dose should only be increased on medical advice. The inhalation of the content of one 300 µg capsule once a day, using the Onbrez Breezhaler inhaler, has been shown সম্পূর্ণ নথি পড়ুন